Archives for March 20, 2007

← 2007

Bradman Lake sheds packaging brands in restructuring

By  Anna Lewcock

Packaging technology firm Bradman Lake is selling off recently acquired brands Albro, Dico and Gravfil only months after investing in a new multi-million pound manufacturing facility.

Talks over new Covance facility 'positive'

By  Emilie Reymond

The mayor of a US city where Covance is planning to build a controversial new preclinical testing facility met last week with the Food and Drug Administration (FDA) and government officials to discuss the animal testing issues surrounding the plans.

Alexion: the NME of blood disease

By  Mike Nagle

Patients suffering from a rare and life threatening blood disorder received a boost when the first ever drug to treat the disease was approved.

Sony PS3 powers Alzheimer's research

By  Mike Nagle

Scientists hope to harness the power of Sony's new PlayStation 3 games console to conduct research on protein folding and associated diseases such as Alzheimer's and cancer.

AtheroGenics rethink strategy for heart drug

By  Mike Nagle

A novel drug designed to prevent coronary heart disease has failed a pivotal clinical trial although the developers are hopeful the drug might still win approval.

Baxter to increase research spending

By  Dr Matt Wilkinson

Baxter has pledged to invest a greater proportion of its profit in R&D, to bring the company in line with other pharma firms.